Morepen Laboratories Ltd Share Price

Q: What is the share price of Morepen Laboratories Ltd today?

Morepen Laboratories Ltd share price as on 22 Jan 2025 is ₹66.19

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: MOREPENLAB Small Cap ISIN: INE083A01026

As on 22 January 2025 at 18:33 IST

₹66.19

-1.18

(-1.75%)

Sell Buy

Over 1 Month

-14.41%

Over 6 Months

22.16%

Over 1 Year

52.94%

Over 3 Years

29.19%

Morepen Laboratories Ltd Summary

Close ₹ 66.19

Open ₹ 67.80

High ₹ 68.15

Low ₹ 64.72

Volume 29,38,022

Net Turnover (in ₹) ₹ 29,72,67,377.36

52Wk High ₹ 100.90

52Wk Low ₹ 38.55

52Wk High / Low

38.55

100.90

Morepen Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 3,691.56

EPS (TTM) 2.59

Book Value (BV) 20.95

Div. Yield -

P/E (TTM) 26.05

Price/Book Value 3.22

Delivery % 37.86 %

Face Value 2

Key Ratios

PE Ratio 19.38

PB Ratio 2.42

EV to Sales 1.38

PEG Ratio 0.14

ROA 11.69

ROE 13.29

Debt-Equity 0.03

Net Profit Margin 7.22

Operating Profit Margin 11.34

Morepen Laboratories Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,704.40	1,423.66	1,557.13	1,200.13	862.55
Total Expenses	1,568.99	1,367.91	1,430.43	1,101.61	823.44
Profit Before Tax	135.42	55.76	126.70	98.51	39.11
Profit After Tax	96.62	38.68	101.68	97.09	33.58
Operating Profit after Depreciation	139.13	57.74	119.34	100.30	41.09

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	307.35	266.97	251.80	224.52	216.37
Total Non Current Assets	404.16	354.33	335.75	331.36	291.29
Total Current Assets	889.04	756.16	734.30	526.79	372.18
TOTAL ASSETS	1,293.21	1,110.50	1,070.05	858.15	663.46
Total Shareholder's Fund	847.23	752.91	578.56	424.75	284.06

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	73.37	-91.17	-60.24	50.83	11.02
Net Cash used in Investing Activities	-83.30	-46.51	-31.68	-70.35	-12.46
Net Cash used in Financing Activities	5.20	143.54	66.33	47.27	5.49

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,550.16	1,344.64	1,459.50	1,124.20	801.40
Total Expenses	1,401.18	1,281.60	1,333.96	1,029.95	763.92
Profit Before Tax	148.98	63.04	125.54	94.25	37.48
Profit After Tax	110.94	46.24	101.06	94.25	32.33
Operating Profit after Depreciation	152.48	65.02	118.18	96.04	39.45

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	216.54	170.82	156.11	144.02	134.84
Total Non Current Assets	436.40	374.69	356.50	354.71	313.73
Total Current Assets	842.91	730.85	676.76	492.79	348.26
TOTAL ASSETS	1,279.31	1,105.54	1,033.26	847.50	661.99
Total Shareholder's Fund	889.02	780.11	598.17	444.97	307.25

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	77.36	-102.12	-68.87	49.31	10.86
Net Cash used in Investing Activities	-83.60	-36.20	-22.64	-69.09	-12.08
Net Cash used in Financing Activities	0.28	144.20	66.41	47.46	4.65

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	437.73	455.22	423.07	444.55	421.77
Total Expenses	393.65	403.59	374.70	393.98	388.18
Profit Before Tax	46.03	48.18	42.19	44.02	28.68
Profit After Tax	34.85	36.17	28.74	31.99	21.26
Operating Profit after Depreciation	49.07	55.06	52.61	54.64	36.83

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	383.70	385.64	392.60	394.63	381.26
Total Expenses	340.64	337.03	336.46	343.51	351.50
Profit Before Tax	42.85	47.05	52.71	47.23	27.34
Profit After Tax	31.93	35.05	39.96	35.20	19.92
Operating Profit after Depreciation	47.69	51.68	60.13	54.78	32.60

Morepen Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 65.83

S2 64.28

S3 61.54

Pivot 68.57

R1 70.12

R2 72.86

R3 74.41

Moving Average

20 SMA 72.98

50 SMA 78

100 SMA 81.69

200 SMA 67.97

Morepen Laboratories Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 27 Sep 2022

AGM 27/09/2022 Pursuant to Regulation 30 read with Part A of Schedule III of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed notice of 37th Annual General Meeting ('AGM') of Morepen Laboratories Limited ('the company'), scheduled to be held on Tuesday, 27th September 2022 at 12.30 p.m. (IST) through Video Conferencing/ Other Audio Video Means ('VC'/''OAVM'), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. (As Per BSE Announcement dated on 02.09.2022) Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that 37th Annual General Meeting of Morepen Laboratories Limited ('Company'), was held today i.e., Tuesday, September 27, 2022, through Video Conferencing/Other Audio-Visual Means. The proceeding of the said meeting is annexed herewith. (As Per BSE Announcement dated on 27.09.2022) This is to inform that 37th Annual General Meeting ('AGM') of Morepen Laboratories Limited ('the company') was held on Tuesday, September 27, 2022, through video conferencing/ other audio-visual means. Mr. Praveen Dua, Proprietor of PD and Associates, Practising Company Secretaries, was appointed as the 'Scrutinizer' to scrutinize the voting process in fair and transparent manner. The consolidated Scrutinizer's Report dated September 27, 2022 is attached herewith as Annexure-I. In terms of the provisions of Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the details of voting results are also attached herewith as Annexure-II. (As per BSE Announcement Dated on 28/9/2022)

AGM Date: 28 Sep 2023

AGM 28/09/2023

AGM Date: 28 Sep 2024

AGM 28/09/2024 Please find enclosed proceedings of the 39th Annual General Meeting held through VC/ OAVM on Saturday, 28th September 2024 at 1.00 p.m. (IST). (As per BSE Announcement Dated on 28/09/2024)

EGM Date: 05 Mar 2022

EGM 05/03/2022 Pursuant to Regulation 30 read with Part A of Schedule III of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed Notice of the Extra-Ordinary General Meeting ('EGM') of the members of Morepen Laboratories Limited ('the Company'), scheduled to be held on Saturday, 5th March, 2022 at 4.00 p.m. (I.S.T.) through Video Conferencing/ Other Audio Video Means ('VC'/ 'OAVM'), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. . (As per BSE Announcement Dated on 11/02/2022) This is in reference to the notice dated 8th February 2022 ('EGM Notice') convening the Extra-Ordinary General Meeting of the shareholders ('EGM') of Morepen Laboratories Limited (the 'Company') scheduled to be held on Saturday, 5th March 2022 at 4.00 p.m. (I.S.T.) through Video Conferencing/ Other Audio Video Means ('VC'/ 'OAVM') to transact the business as set out therein. The Corrigendum to the said notice is attached herewith. (As per BSE Announcement Dated on 26/02/2022) Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, we would like to submit the proceedings of the Extra-Ordinary General Meeting of Morepen Laboratories Limited ('Company'), held today i.e., Saturday, 5th March, 2022, at 04.00 p.m. through Video Conferencing/Other Audio-Visual Means. ('VC'/ 'OAVM'). Please find attached Voting Results of the Extra-Ordinary General Meeting held on Saturday, 5th March, 2022 at 4.00 P.M. (I.S.T.) through Video Conferencing/ Other Audio Video Means ('VC'/ 'OAVM') (As per BSE Announcement Dated on 5/3/2022) Morepen Laboratories Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 07.03.2022)

EGM Date: 18 Mar 2024

Please find enclosed newspapers advertisements dated 25/02/2024, inter-alia, confirmation of dispatch of notice of Extra-Ordinary General Meeting scheduled to be held on Monday, 18/03/2024 at 11.30 a.m. (IST) through VC/ OAVM along-with details of e-Voting. Please find attached notice of Extra-Ordinary General Meeting scheduled to be held on Monday, March 18, 2024 at 11.30 a.m. (IST) through VC/ OAVM along-with details of e-Voting and cut off date. (As Per BSE Announcement Dated on 24.02.2024) Please find attached proceedings of the Extra-Ordinary General Meeting held on Monday, March 18, 2024, through VC/ OAVM, at 11.30 am (IST). Please find attached Scrutinizer'' Report along-with voting results in compliance with Regulation 44 of SEBI (LODR) Regulations, 2015, as amended. (As per BSE Announcement Dated on 18/03/2024)

EGM Date: 10 Feb 2025

Please find enclosed notice of an Extra-Ordinary General Meeting scheduled to be held on Monday, February 10, 2025 at 2.00 p.m. (IST) through VC/ OAVM. Please find enclosed newspaper advertisements dated 18/01/2025, inter-alia confirming of dispatch of notice of EGM scheduled to be held on Monday, 10/02/2025 at 2:00 p.m. through VC/OAVM along with details of e-voting. (As Per BSE Announcement Dated on 18/01/2025)

Morepen Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Morepen Laboratories Ltd	₹67.47	₹3,697.04
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Morepen Laboratories Ltd News

Morepen Laboratories to discuss results

On 11 November 2024

08 Nov 2024, 10:49 am

Morepen Laboratories schedules AGM

On 28 September 2024

12 Sep 2024, 04:01 pm

Morepen Laboratories appoints director

With effect from 27 August 2024

27 Aug 2024, 03:31 pm

Morepen Labs soars after stellar Q1 performance

Morepen Laboratories jumped 4.70% to Rs 60.86 after the company reported a consolidated net profit of Rs 36.17 crore in Q1 FY25, which is a rise of 147% as compared with the PAT of Rs 14.63 crore in Q1 FY24.

12 Aug 2024, 12:44 pm

Morepen Laboratories to announce Quarterly Result

On 12 August 2024

10 Aug 2024, 04:53 pm

Morepen Laboratories Ltd Stock Analysis

Annual revenue for Morepen Laboratories Ltd increased by 15.28% to ₹1,550.16 crore in FY 2024 from ₹1,344.64 crore in FY 2023.
Annual Net Profit for Morepen Laboratories Ltd increased by 139.90% to ₹110.94 crore in FY 2024 from ₹46.24 crore in FY 2023.
Promoter Shareholding in Morepen Laboratories Ltd remains unchanged by 0.00% in the most recent quarter, from 35.65% in September 2024 to 35.65% in December 2024.
Morepen Laboratories Ltd delivered a 1-year return of 52.94% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Morepen Laboratories Ltd share price moved down by 1.75% from its previous close of INR ₹67.37. The latest Morepen Laboratories Ltd share price is INR ₹66.19.
Morepen Laboratories Ltd share price today has been at a low of 64.72 and a high of 68.15. Over the past 52 weeks, the Morepen Laboratories Ltd share price has seen a low of 38.55 and a high of 100.90.